Toggle light / dark theme

Psychedelics are known for inducing altered states of consciousness in humans by fundamentally changing our normal pattern of sensory perception, thought and emotion. Research into the therapeutic potential of psychedelics has increased significantly in the last decade.

While this research is important, I have always been more intrigued by the idea that psychedelics can be used as a tool to study the neural basis of human consciousness in laboratory animals. We ultimately share the same basic neural hardware with other mammals, and possibly some basic aspects of consciousness, too. So by examining what happens in the brain when there’s a psychedelically induced change in conscious experience, we can perhaps glean insights into what consciousness is in the first place.

We still don’t know a lot about how the networks of cells in the brain enable conscious experience. The dominating view is that consciousness somehow emerges as a collective phenomenon when the dispersed information processing of individual neurons (brain cells) is integrated as the cells interact.

A team of scientists took a bunch of macaque monkeys, made them into alcoholics, and then successfully weaned them off the sauce after injecting their brains with a special gene — an experiment, detailed in a new paper published in Nature Medicine, that could potentially provide a compelling new treatment for addiction.

“Drinking went down to almost zero,” Oregon Health and Science University professor and co-author Kathleen Grant told The Guardian. “For months on end, these animals would choose to drink water and just avoid drinking alcohol altogether.”

The researchers set out with the premise that continued alcohol use causes changes to neurons and hampers the dopamine “reward circuitry” in the brain.

Since this book is about what I consider intellectual subject matter, I think it’s relevant to keep brains in top shape and thought it would be important to share this. You probably know about this sort of thing but I didn’t know the specific nutrients needed and what was lacking in people with Alzheimer’s. Best wishes.


Alzheimer’s disease is a progressive neurodegenerative disease estimated to affect 6 million Americans and 33 million people worldwide. Large numbers of those affected have not yet been diagnosed.

A new study published in the Journal of Alzheimer’s Disease by a Virginia Tech Carilion School of Medicine faculty member shows that brain levels of dietary , zeaxanthin, lycopene, and vitamin E in those with Alzheimer’s disease are half those in normal brains. Higher dietary levels of lutein and zeaxanthin have been strongly linked to better cognitive functions and lower risk for dementia or Alzheimer’s disease.

“This study, for the first time, demonstrates deficits in important dietary antioxidants in Alzheimer’s brains. These results are consistent with large population studies that found risk for Alzheimer’s disease was significantly lower in those who ate diets rich in , or had high levels of lutein and zeaxanthin in their blood, or accumulated in their retina as macular pigment,” said C. Kathleen Dorey, professor in the Department of Basic Science Education at the medical school. “Not only that, but we believe eating carotenoid-rich diets will help keep brains in top condition at all ages.”

The John Templeton Foundation recently invited biologist Michael Levin to speak to a small group about the presence of agency and cognition in the most fundamental forms of life, even at the levels of cells and tissues. In the recorded video, Dr. Levin, who directs a developmental biology lab at Tufts University, discusses with Philip Ball, a science writer and author of the newly published Book of Minds: How to Understand Ourselves and Other Beings.

Founded in 1987, the John Templeton Foundation supports research and dialogue on the deepest and most perplexing questions facing humankind. The Foundation funds work on subjects ranging from black holes and evolution to creativity, forgiveness, and free will. It also encourages civil, informed dialogue among scientists, philosophers, theologians, and the public at large.

With an endowment of $3.8 billion and annual giving of approximately $140 million, the Foundation ranks among the 25 largest grantmaking foundations in the United States. Headquartered outside Philadelphia, its philanthropic activities have engaged all major faith traditions and extended to more than 57 countries around the world.

To learn more, check out Templeton.org or follow us on social:

Instagram: https://www.instagram.com/templetonfo
Twitter: https://twitter.com/templeton_fdn.
Facebook: https://www.facebook.com/TempletonFou
Linkedin: http://bit.ly/jtflinkedin

A research team co-led by City University of Hong Kong (CityU) and The University of Hong Kong (HKU) has recently made a significant advancement in spinal cord injury treatment by using genetically-modified human neural stem cells (hNSCs).

They found that specifically modulating a to a certain level in hNSCs can effectively promote the reconstruction of damaged neural circuits and restore locomotor functions, offering great potential for new therapeutic opportunities for patients with spinal cord . The findings were published in the journal Advanced Science under the title “Transplanting Human Neural Stem Cells with ≈50% Reduction of SOX9 Gene Dosage Promotes Tissue Repair and Functional Recovery from Severe Spinal Cord Injury.”

Traumatic spinal cord injury is a devastating condition that commonly results from accidents such as falls, car crashes or sport-related injuries.

Scientists found a way to translate brain waves into music, using a Pink Floyd song — here’s how the tech could be used for communication in the future.
» Sign up for our newsletter KnowThis to get the biggest stories of the day delivered straight to your inbox: https://go.nowth.is/knowthis_youtube.
» Subscribe to NowThis: http://go.nowth.is/News_Subscribe.

For more science and news, subscribe to @NowThisNews.

#pinkfloyd #music #science #Politics #News #NowThis.

Connect with NowThis.
» Like us on Facebook: http://go.nowth.is/News_Facebook.
» Tweet us on Twitter: http://go.nowth.is/News_Twitter.
» Follow us on Instagram: http://go.nowth.is/News_Instagram.
» Find us on Snapchat Discover: http://go.nowth.is/News_Snapchat.

NowThis is your premier news outlet providing you with all the videos you need to stay up to date on all the latest in trending news. From entertainment to politics, to viral videos and breaking news stories, we’re delivering all you need to know straight to your social feeds. We live where you live.

https://www.youtube.com/nowthisnews.

A recent study study sheds light on how a protein called amyloid precursor protein (APP) affects the growth of nerve cells in the cortex — the human brain’s outer layer. The findings suggest that APP plays a crucial role in maintaining the delicate balance between neural stem cell proliferation and differentiation during the early stages of brain development.

The research, published in Science Advances, could have important implications for our understanding of neurodevelopmental processes and neurodegenerative diseases.

APP is a class I transmembrane protein that is widely expressed during nervous system development. It has been extensively studied due to its connection to Alzheimer’s disease (AD), where its fragmentation produces amyloid peptides that contribute to neuronal death. However, the physiological function of APP, especially in the context of human brain development, has remained unclear.

A team of scientists recently aimed to better understand consciousness and its pathologies by studying the neural activity of patients with disorders of consciousness and healthy volunteers using brain imaging technology. They identified two crucial brain circuits implicated in consciousness. The results of the study have been published in Human Brain Mapping.

Consciousness is a complex and subjective experience, and there is still much debate among scientists and philosophers about its nature and origin. However, in clinical settings, doctors treating patients with severe brain injuries and disorders of consciousness need to find ways to help their patients, regardless of the exact definition of consciousness. The authors of the new study sought to better understand the mechanisms behind the pathological loss of consciousness and its recovery, as well as to have reliable ways to assess the state of the patients.

“In recent years, many studies have tried to objectively assess levels of consciousness using various neuroimaging techniques. While these studies have improved how we diagnose patients with disorders of consciousness, they haven’t fully explained how consciousness comes about,” explained study author Jitka Annen, a postdoctoral researcher at the Coma Science Group at the University of Liege.